Last updated at 29 Jun 2024 04:15 PM
Director
DIN: 09818407
Shilpa Jain is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SHREE VARDHMAAN SURGICARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09818407.Shilpa Jain has previously been associated with 2 companies in roles such as Additional Director.Shilpa Jain is currently involved in 2 different roles. Their most recent position is with MSB CHEMICAL LIMITED as a Director. The first company Shilpa Jain was appointed to as a director was SHREE VARDHMAAN SURGICARE PRIVATE LIMITED. Shilpa Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Shilpa Jain is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SHREE VARDHMAAN SURGICARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09818407.Shilpa Jain has previously been associated with 2 companies in roles such as Additional Director.Shilpa Jain is currently involved in 2 different roles. Their most recent position is with MSB CHEMICAL LIMITED as a Director. The first company Shilpa Jain was appointed to as a director was SHREE VARDHMAAN SURGICARE PRIVATE LIMITED. Shilpa Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1y 10m 11 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SHREE VARDHMAAN SURGICARE PRIVATE LIMITED | Individual Promoter | 13-Oct-2016 |
| MSB CHEMICAL LIMITED | Director | 30-Sep-2023 |